
Laura Rodríguez
@laurg87
Followers
426
Following
866
Media
121
Statuses
990
Partner at Invivo Partners. PhD in Biotechnology.
Barcelona
Joined March 2012
RT @InvivoPartners: INTERNSHIP OPPORTUNITY: Are you willing to start a career in the #VentureCapital space? Apply now!. 🗓Deadline: 5th Dece….
0
1
0
RT @InvivoPartners: EVENT: Today, @laurg87 participated in the roundtable organized by @Itemas on "The Role of Institutions in Participated….
0
2
0
Engaging discussion on challenges, trends, and value drivers shaping the C> space, and the potential growth opportunities in Europe at #ATE24.At @InvivoPartners , we believe the C> field will advance into new indications, novel cell types, and cutting-edge technologies.
0
1
2
RT @Menendez_Lab: Lovely summary by Drs Luis Pareras and Cinta Díez at @InvivoPartners in interesting strategies to bypass T cell dysfunct….
0
4
0
I'm delighted to be speaking at Advanced Therapies Europe, September 2024. Register now to join me at the No.1 event for the Cell & Gene Therapy industry! #ATE24
invt.io
Register now
0
0
5
RT @InvivoPartners: Laura Rodríguez @laurg87 will participate at the Oncology Innovation Panel with Ines Ullmo, Bettina Ernst, Ruben Sebast….
0
1
0
RT @InvivoPartners: EVENTS: Join Laura Rodríguez @laurg87, Partner and Gemma Guinart @gemmagnrt, Principal at Invivo Partners, at #AseBioID….
0
1
0
RT @InvivoPartners: EVENTS: Laura Rodríguez , Partner and Gemma Guinart, Principal at Invivo Partners are attending #BioEquity! Eager to ma….
0
1
0
RT @InvivoPartners: PORTFOLIO NEWS: Our portfolio company @onechaintx has announced the first patient dosed in the #CARxALL clinical trial….
0
1
0
RT @InvivoPartners: Yesterday, @laurg87, Partner at Invivo, participated in a roundtable with Marina Rigau (@mimarkdx) and Antoni Rosselló….
0
1
0
RT @InvivoPartners: INTERNSHIP OPPORTUNITY: Are you willing to start a career in the #VentureCapital space? Apply now!.🗓Deadline extended t….
0
1
0
RT @InvivoPartners: INTERNSHIP OPPORTUNITY: Are you willing to start a career in the hashtag#VentureCapital space? Our internship program i….
0
1
0
RT @InvivoPartners: PORTFOLIO NEWS: Welcome Michael Tadros, new CEO at Telomere. With his vast expertise in science, tech transfer, and bio….
linkedin.com
PORTFOLIO NEWS: We are thrilled to welcome Michael Tadros Ph.D. as the new CEO of Telomere Therapeutics. His extensive experience in science, technology transfer and biotech management will steer the...
0
1
0
RT @InvivoPartners: PORTFOLIO NEWS: Excited to welcome Subhendu Basu as CEO of @Telum_Tx. With 20+ years in biotech and pharma, his leaders….
linkedin.com
PORTFOLIO NEWS: We are thrilled to welcome Subhendu Basu Ph.D. as CEO of Telum Therapeutics. With over twenty years of experience in biotech and in the pharma industry, Subhendu is a seasoned leader...
0
1
0
RT @InvivoPartners: Big News!.Thrilled to announce @gemmagnrt Gemma Guinart Mola's promotion to Principal at Invivo Partners! After years o….
0
2
0
Honored to step into my new role as Partner at @InvivoPartners, as we announce the preparation of a €100M 3rd Fund to nurture the next wave of innovation in life sciences, with a focus on ATMPs, synbio, and AI. Excited for the road ahead and the impact we'll make together.
INVIVO III/ Thrilled to announce we are preparing the closing of III fund, aiming for €100-120M (cell & gene therapy + synthetic biology + AI). @laurg87 is now Partner. Having Laura is a privilege; she stands out as one of the most talented individuals I have ever encountered.
4
4
37
RT @InvivoPartners: PORTFOLIO NEWS: @onechaintx secured ~ €2M from the Spanish Ministry of Science and Innovation, propelling a second CAR….
linkedin.com
PORTFOLIO NEWS: Thrilled to announce that OneChain Immunotherapeutics has received ~ €2M from the Spanish Ministry of Science and Innovation! This funding will propel a second CAR T candidate based...
0
2
0
RT @InvivoPartners: PORTFOLIO NEWS: @Arthexbiotech has secured FDA clearance for Phase I-IIa trials of ATX-01 in Myotonic Dystrophy Type 1.….
0
3
0
RT @InvivoPartners: EVENTS: Today, Luis @pareras, Managing Partner at Invivo Partners, participates at a round table with Esteve Trias, So….
0
1
0